How do I choose the best treatment options for MY multiple myeloma (MM)? With more multiple myeloma treatments being approved and personalized for myeloma patients, Drs. Gareth Morgan, Faith Davies and Frits van Rhee, from the University of Arkansas for Medical Sciences (UAMS) Myeloma Institute, discuss the expanding armamentarium. Dr. Morgan reviews immunomodulatory therapies (IMIDs), checkpoint inhibitors and the continued role of chemotherapy. Dr. Davies focuses on proteasome inhibitors, while Dr. van Rhee explains monoclonal antibodies and antibody conjugates.
Clinical Trials Mentioned in This Program